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ABSTRACT
Background.Medications are not exempt from adverse drug reactions (ADR) and how
the physician perceives the risk of prescription drugs could influence their availability to
report ADR and their prescription behavior.
Methods.We assess the perception of risk and the perception of ADR associated with
COX2-Inbitors, paracetamol, NSAIDs, andmorphine inmedical students and residents
of northeast of Mexico.
Results. The analgesic with the highest risk perception in both group of students was
morphine, while the drug with the least risk perceived was paracetamol. Addiction
and gastrointestinal bleeding were the ADR with the highest score for morphine and
NSAIDs respectively.
Discussion. Our findings show that medical students give higher risk scores than
residents toward risk due to analgesics. Continuing training and informing physicians
about ADRs is necessary since the lack of training is known to induce inadequate use
of drugs.
Subjects Anaesthesiology and Pain Management, Drugs and Devices, Pharmacology, Public
Health, Science and Medical Education
Keywords Adverse drug reactions, Risk perception, Medical students, Morphine, NSAIDs,
Mexico
INTRODUCTION
Analgesics are the cornerstone of pain management and their availability is critical for to
alleviate unnecessary chronic and acute pain, especially in developing countries (Lohman,
Schleifer & Amon, 2010). However, these medications are not exempt from adverse
reactions (ADR). The use of opioids is associated with various ADRs ranging from nausea
and vomiting to urinary retention and respiratory depression. Paracetamol is relatively
safe when taken in a therapeutic dose (≤4 g/day for adults). However, overdosage leads
to hepatotoxicity and nephrototoxicity (Chun et al., 2009; Waring, Jamie & Leggett, 2010;
Hodgman & Garrard, 2012). Non-Steroidal Anti-inflammatory-drugs (NSAIDs) can result
in gastrointestinal (GI) complications, ranging from dyspepsia to peptic ulcer and GI
bleeding (Castellsague et al., 2012). On the other hand, COX2 inhibitors could create an
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ulcerogenic dual-COX inhibitor when administered with low-dose aspirin. Moreover, by
inhibiting COX2, they could delay ulcer healing. Similar to traditional NSAIDs, COX2
inhibitors compromise the glomerular filtration rate in patients at increased risk, and may
cause peripheral edema and hypertension. In combination with an oral anticoagulant they
increase the international normalized ratio (Mattia & Coluzzi, 2005).
On the other hand, how the physician perceives the risk of prescription drugs could
influence their availability to report ADR and their prescription behavior. With opioids,
an apprehensive attitude when using morphine as an analgesic could lead to resistance
to administer morphine to patients suffering from severe pain. Such reluctance can have
a negative impact on pain management as well as quality of life (Joranson et al., 2000;
Bandieri et al., 2009).
With this in mind, the aims of this study was (1) to assess the risk perception of medical
students (MS) and residents (Rs) towards the normal use of opioid and non-opioid
analgesics, and (2) to assess the perception of common ADR caused by morphine and
NSAIDs.
METHODS
This study was conducted in the Faculty of Medicine of the Autonomous University of
Nuevo León (UANL) and the Dr José E. Gonzalez University Hospital, both located in the
Metropolitan area of Monterrey, Mexico. The sample of MS was conformed by those who
had already taken a pharmacology course and were surveyed in the faculty of medicine
(halls, study areas, library). The sample of Rs include those of any specialty and year of
residence and were surveyed in the hospital.
After informing the aim of the study and obtaining verbal consent of the participants,
the survey was applied. Participants were informed that the first section was optional. The
questionnaire was self-administered with supervision.
Instrument
The instrument was composed of three sections: the first section is general questions about
gender, age and year of study or year of residence, as appropriate. This section was optional;
the second section evaluated risk perception to analgesics when normal dosing was used;
it included COX2-inhibitors, paracetamol, morphine and NSAIDs. This was performed as
previously reported by Durrieu et al. (2007) and Durrieu et al. (2010). A visual analogue
scale of 10 cm ranging from 0 (drug without risk) to 10 (highly risky drug) was used to
assess perceived risk to each one of the analgesics previously mentioned. The value was
obtained by measuring the distance between the left side of the scale (equal to zero) and
the mark made by the participant. Since each scale measured 10 cm, risk perception could
be considered a quantitative score ranging from 0 to 10. The third section evaluated risk
perception to specific ADR when normal use of morphine and NSAIDs were used. The
ADR evaluated were gastrointestinal (GI) bleeding, kidney damage, liver damage, sedation,
bronchospasm, and addiction. Each adverse effect was assessed as a risk perception; that is,
a visual analogue scale of 10 cm ranging from 0 (absent effect) to 10 (effect very frequent).
Morphine was chosen due to the fact that it is a better-known opioid; therefore, it is a good
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Figure 1 Risk perception toward different analgesic betweenmedical students and residents.
representative of opioid analgesics. NSAIDs were chosen due to the fact that they are very
familiar drugs to all students and they are a good representation of non-opioid analgesics.
Statistical analysis
Normality of data was tested with the Kolmogorov–Smirnov test. Data are reported as
median and 25th–75th percentiles. The Mann–Whitney U -test was used for comparison
between two groups of students and between males and females. The statistical package
SPSS V20 and NCSS-10 were used for all analyses.
Ethical approval and consent
The Ethics committee of the Faculty of Medicine of the Autonomous University of Nuevo
León approved this study and exempted from written informed consent. The reference
number is AN15-011.
RESULTS
Five hundred and five students were interviewed. Women and men represented 39.7% and
60.3%, respectively. MS on the other hand, represented 58.9% and Rs 41.1%.
Risk perception to analgesics
Overall, the analgesic with the highest risk perceptionwasmorphine, while the drugwith the
least risk perceived was paracetamol (Fig. 1). This pattern was observed in MS and Rs of all
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Table 1 Risk perception to analgesics by year of study (median and interquartile range).
Degree Year Paracetamol COX2 inhibitors NSAIDs Morphine
3 1 (0.3–2.5) 4 (2.5–5) 2.3 (1.5–4) 6 (3.5–8.5)
4 1.3 (0.5–2) 3 (2.5–5) 3 (2.2–5) 6 (4–7.5)
5 0.8 (0.4–2) 3.7 (2.5–5.3) 3.5 (2–5) 5.5 (2.7–8)
6 1 (0–2) 3 (1.5–5) 3 (1.7–5) 4 (2–6)
Medical
students
P value 0.25 0.09 0.03 0.00
1 1 (0.3–1.7) 1.8 (0.9–3.1) 2.3 (1.2–3.7) 3.8 (2.5–5.3)
2 1 (0.3–1.8) 2 (1–3) 2.5 (1.3–3.8) 4 (1.8–6.5)
3 1.5 (0.7–2) 2 (1–3.4) 2.5 (1.7–3.5) 3 (2.2–5.4)
4 1.2 (0–1.8) 2 (1.1–2.5) 2 (1.4–3.5) 3.3 (1.8–5.2)
Residents
P value 0.4 0.9 0.9 0.8
Table 2 Risk perception to Analgesics betweenmedical students and residentsa according their gender (median and interquartile range).
COX2 inhibitors Paracetamol Morphine NSAIDs
MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P
Total
(N = 509)
3.3
(3–3.7)
2.0
(1.7–2)
0.00 1.0
(1–1)
1.0
(1–1.2)
0.70 5.0
(5–6)
3.4
(3.1–4)
0.00 3
(2.7–3.3)
2.3
(2–2.5)
0.00
Male
(N = 307)
3.5
(3–4)
2.0
(1.7–2.5)
0.00 1.0
(1–1.3)
1
(0.8–1.2)
0.29 5.26
(2.64)
3.95
(2.31)
0.00 3.0
(2.8–3.5)
2.5
(2–2.7)
0.00
Female
(N = 202)
3
(2.7–3.8)
1.8
(1.2–2)
0.00 1.0
(0.5–1)
1.0
(0.7–1.5)
0.52 5.0
(4.5–6.2)
3.4
(2.9–4)
0.00 2.8
(2.3–3.3)
2.2
(2–2.6)
0.02
P value 0.10 0.12 0.04 0.57 >0.05 0.91 0.19 0.50
Notes.
MS, Medical students; R, Residents; P , <0.05; S, Significant; NS, Nonsignificant.
aComparison between MS and R was with Mann–Whitney test.
years of study (Table 1). In the case of MS, there was a significant difference among years of
study and perception of risk to morphine and NSAIDs. For morphine, the higher risk score
was observed in 3rd year medical students while the lowest score was in 6th year medical
students. For NSAIDS, this was the opposite. With respect to Rs, there no was a significant
difference between year of residence and risk perception score for each one analgesic.
MS had greater scores in risk perception than Rs (Table 2). This difference was significant
for COX2 inhibitors, morphine and NSAIDs. These high scores were also observed in both
genders of MS. Significant differences between females and males was observed only for
paracetamol in MS (P = 0.04) (Table 2).
Risk perception to ADR
For morphine, addiction and GI bleeding were the ADR with the highest and lowest scores,
respectively in MS (8 and 5 respectively) and Rs (6.2 and 2.5 respectively). This pattern was
observed in all years of study of both group of students (Table 3). There nowere a significant
difference among years of study ofMS and risk perception of ADR except for bronchospasm
(P = 0.02). In the case of Rs, there no were a significant difference among year of residence
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Table 3 Risk perception of adverse drug reactions due to morphine and NSAIDS by year of study.
Degree Year Morphine NSAIDS
GI
bleeding
Kidney
damage
Liver
injury
Sedation Broncho
espasma
Addiction GI
bleeding
Kidney
damge
Liver
injury
Sedation Broncho
espasma
Addiction
3 5
(3–7)
5
(3–6.5)
5
(2.8–7.5)
8.5
(6.7–9.3)
5.5
(3.5–7)
8.7
(7–9.6)
7.7
(6.5–9)
6.5
(5–7.7)
6.5
(5–8)
3.7
(1.5–5.7)
3.3
(1.5–5.7)
2.7
(1.3–5)
4 5
(2.7–5.3)
5
(3.5–6.5)
5.7
(4.3–6.7)
7.3
(6–8.7)
6
(5–7.5)
8
(6–9)
7.5
(6–8.6)
6
(5–7.6)
6
(4–7.7)
3.3
(2–5)
3
(2–5)
2.5
(1–6)
5 4.5
(2.5–6)
5
(3.5–6.7)
5
(3.5–6.7)
7.5
(5.5–9)
6
(3.7–7.3)
8
(6.5–9.5)
8
(5.7–9)
7
(5–8.5)
7
(4.3–8.1)
4.5
(2–6.5)
3.2
(1.7–5)
2.5
(1–5)
6 4.2
(2–6)
4.1
(2–6.4)
5
(2.7–6.3)
8
(7–9)
5
(3–7)
8.5
(7–9.7)
8
(6.5–9)
7
(5–8.5)
6.5
(4.7–9)
3
(1.5–5)
3
(1.5–5)
2
(1–4)
Medical
students
P value 0.4 0.21 0.11 0.08 0.02 0.18 0.43 0.03 0.61 0.22 0.76 0.57
1 2.2
(1.2–3.8)
2.9
(1.9–4.8)
4.2
(2.2–5.5)
6.3
(4–8.1)
4.5
(2.4–5.4)
6.6
(5.4–8.1)
7.1
(5.7–8.2)
6
(4.5–7.5)
4.7
(2.2–6.1)
2
(1.2–3.2)
2
(1.4–2.9)
2.2
(1.2–3)
2 2.4
(1–4)
3
(1.4–4.8)
3
(1.9–5)
6.3
(3.6–8)
3.2
(1.7–5.5)
5.8
(3.1–7.4)
6.5
(4.3–8.3)
6.1
(2.7–7)
3.6
(1.5–6)
1.7
(0.3–2.8)
2
(1–3)
1.7
(0.7–2.8)
3 2.6
(1–3.3)
3
(1.8–5.4)
3.8
(2–5.8)
6.2
(4–7.6)
4.3
(2–6.6)
6
(4.4–8.2)
7.2
(5.7–8.7)
6.8
(4.3–8)
4.8
(1.5–6.5)
1.5
(0.7–3.2)
2.1
(1–3.5)
2
(0.8–3.3)
4 2.6
(1.6–4)
3.8
(2.4–5.6)
4.1
(3–5.7)
6.5
(5.7–7.6)
3.5
(2–5.8)
7
(5.4–7.4)
7
(6.4–8)
6.7
(5.1–7.8)
5.3
(2.9–7)
2.6
(1.7–3.3)
2.5
(1.8–3.2)
2.5
(1.5–3.2)
Residents
P value 0.6 0.3 0.6 0.8 0.7 0.3 0.5 0.3 0.1 0.08 0.4 0.2
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and risk perception of ADR due to morphine. On the other hand, MS showed significant
higher scores than residents in the risk perception of ADR due to morphine (Table 3); this
was similar in both genders of this group of students (Table 4). Significant differences
between genders were observed in GI bleeding and sedation in the group of MS and Kidney
damage in the case of residents.
For NSAIDs, the ADR with the highest score in both MS and residents, was GI bleeding
(7.7 and 7.1, respectively), while the lowest score was addiction (2.5 and 2 respectively).
In the case of MS, there no was a significant difference between year of study and risk
perception to ADR, except for kidney damage (P = 0.03). In residents, there was no
significant difference between year of residence and risk perception to ADR. On the other
hand, MS showed significant higher scores than residents in the ADR due to NSAIDS
except in kidney damage (P = 0.06). There no were significant difference between MS and
Rs according gender in Kidney damage. Also, in the case of GI bleeding, there no were a
significant difference between both groups of students of the female gender (P = 0.09).
Finally, there were a significant difference in GI bleeding and sedation between males and
females of the group of Rs.
DISCUSSION
Previous studies have showed risk perception of drugs in health professionals, students and
patients (Durrieu et al., 2007; Durrieu et al., 2010; Cullen, Kelly & Murray, 2006; Bongard et
al., 2002). However, differences between medical students and residents has been poorly
studied. In addition, studies have focus in several drug class and rarely in a specific drug.
In this study,we searched for differences in the risk perception to the analgesics paracetamol,
COX2 inhibitors, morphine, and NSAIDs between medical students and residents. Our
findings show that medical students give higher risk scores than residents to all analgesics
studied except paracetamol. This was independent of gender. We speculate that this
difference could be explained by the recent courses of pharmacology taken by medical
students. As has been previously showed, the pharmacology course increases global
perception of risk (Durrieu et al., 2007; Durrieu et al., 2010). Others factors, such as the
persuasive methods of pharmaceutical representatives, could affect these perceptions
especially in residents who are more in touch with them than medical students.
In both groups of students, the decreased order of risk perception was as follows:
morphine, NSAIDS, COX2 inhibitors and finally, paracetamol. There no were a significant
difference between medical students and residents in this latter analgesic. We think that the
low risk perceived for paracetamol, when normal doses are used, could have serious
implications. It is probable that participants could be underestimating its potential hepatic
risk. Previous studies have shown that paracetamol even at normal doses can produce liver
injury (Sabate, Ibañez & Pérez, 2011). On the other hand, the highest risk score assigned
to morphine by MS and R could suggest morphinofobia. More studies in this respect are
necessary in Mexican physicians since with our data it is not possible to conclude. The term
morphibophobia can be defined as either a number of beliefs based on the side effects of
morphine prescribed for pain management, or an inadequate management of chronic pain
due to lack of knowledge on how to use morphine (Ferreira et al., 2013).
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Table 4 Risk perception of adverse drug reactions due to morphine and NSAIDS betweenmedical students and residents.
Drugs GI bleeding Kidney damage Liver damage Sedation Bronchospasm Addiction
MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P MS
(n= 300)
R
(n= 209)
P
Morphine
Total
(N = 509)
5.0
(4.3–5)
2.5
(2–2.7)
0.00 5.0
(5–5)
3.1
(2.7–3.4)
0.00 5.0
(5–5.4)
3.6
(3–4)
0.00 8.0
(7.5–8)
6.3
(6–6.8)
0.00 5.5
(5–6)
4
(3.2–4.5)
0.00 8.0
(8–8.5)
6.2
(5.8–6.7)
0.00
Male
(N = 307)
4.5
(4–5)
2.4
(2–2.8)
0.00 5.0
(4.7–5)
2.8
(2.5–3.2)
0.00 5.0
(5–5)
3.3
(2.9–4)
0.00 7.5
(7–8)
6.4
(6–7)
0.00 5.5
(5–6)
4.2
(3–4.7)
0.00 8.0
(8–8.5)
6.5
(6–6.8)
0.00
Female
(N = 202)
5.0
(4.5–5.3)
2.5
(2–3)
0.00 5.0
(5–5.5)
3.5
(3.1–4.3)
0.00 5.0
(5–6)
3.8
(3–4.8)
0.00 8.3
(8–8.5)
6.3
(5.7–7)
0.00 5.5
(5–6)
4.0
(2.7–4.7)
0.00 8.5
(8–9)
6.0
(5–7)
0.00
P value 0.02 0.88 0.14 0.04 0.14 0.37 0.02 0.43 0.84 0.76 0.10 0.52
NSAIDs
Total
(N = 509)
7.7
(7.5–8)
7.1
(6.7–7.3)
0.00 6.5
(6–7)
6.3
(5.9–6.8)
0.06 6.5
(6–7)
4.5
(3.4–4.8)
0.00 3.5
(3–4)
2.0
(1.5–2.2)
0.00 3.1
(3–3.7)
2.0
(2–2.3)
0.00 2.5
(2–3)
2.0
(1.5–2.2)
0.00
Male
(N = 307)
7.5
(7–8)
7.0
(6.4–7.2)
0.00 6.5
(6–7)
6.2
(5.7–6.8)
0.26 6.5
(6–7)
3.7
(3.1–4.7)
0.00 3.5
(3–4.2)
1.65
(1.3–2)
0.00 3.3
(3–4)
2.0
(1.5–2.4)
0.00 2.5
(2–3)
1.7
(1.5–2.2)
0.00
Female
(N = 202)
8.0
(7.3–8.7)
7.3
(6.9–7.8)
0.09 7.0
(6.5–7.5)
6.5
(6–7)
0.10 6.3
(5.5–7)
5.0
(3.7–5.8)
0.00 3.3
(3–4)
2.3
(1.8–3)
0.00 3.0
(2.7–4)
2.3
(2–2.5)
0.00 2.5
(2–3)
2.2
(1.6–2.5)
0.04
P value 0.18 0.04 0.12 0.63 0.94 0.10 0.91 0.00 0.50 0.14 0.44 0.52
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Until now, there are no studies that report risk perception to paracetamol using the in-
strument of this study; therefore, it is not possible establish a comparison. The same applies
to COX2 inhibitors andmorphine. However, regardingNSAIDS, others studies have shown
results different from this work in medical students who have taken a pharmacology course
(median∼= 6.3) (Durrieu et al., 2007) and medical staff (median 6.2) (Bongard et al., 2002).
With regard to perception of ADRs studied, both groups of students scored some level
of risk perception of GI bleeding, kidney damage, liver injury, sedation, bronchospasm and
addiction due to morphine and NSAIDs. GI bleeding had the highest score for NSAIDs,
while addiction had the highest score for morphine. As with paracetamol, COX2 inhibitors
and morphine, there are no studies similar to this study that allow us to compare the
score of GI bleeding and addiction by NSAIDs and morphine, respectively, in health
professionals. However in patients with regular use (Cullen, Kelly & Murray, 2006), the
score reported (median = 3.8) is higher than our population of medical students and
residents. Interestingly, women had higher risk scores than men in some ADR, and the
causes of this are not clear. There are no similar studies that permit a comparison with other
populations; however, it has been reported that women have major risk perception in other
areas such as financial, health/safety, recreational, ethical, and social decisions (Harries &
Jenkins, 2006). Finally, both groups of students score ADRs that are infrequent in NSAIDs
andmorphine, such as GI bleeding and addiction, respectively. The reasons or implications
of this observation are not clear, but merit more research.
Since risk, perception to prescription drugs could influence the availability to report ADR
and their prescription behavior, continuing training and informing physicians about ADRs
is an important issue. In addition, the lack of training is known to induce inadequate use of
drugs (McDowell, Ferner & Ferner, 2009). Poor training also could complicate the transmis-
sion of information to patients regarding ADRs, studies suggest the increase of information
to patients results in a reduction of ADR, hospital admissions, morbidity and cost.
Finally, limitations of this study should be considered, these include the lack of
randomization in the order of items in both ‘‘risk perception to analgesics’’ and ‘‘risk
perception of ADR.’’ Moreover, the risk perception to morphine may not be the same
for all opioids. In addition, our results may not apply to other populations because other
studies are probably different from our sample.
CONCLUSIONS
There is a difference in the risk perception to analgesics between medical students and
residents. The former have a higher risk score toward analgesics than the latter, except for
paracetamol. In both groups of students, the decreasing risk was as follows: morphine,
NSAIDs, COX2 inhibitor and paracetamol. GI bleeding and addiction were the ADRs with
the highest score for NSAIDs and morphine, respectively in both groups.
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